Belarus vs Colombia: Cause of death, by non-communicable diseases, ages 5-14, female
Belarus
50.0%
in 2021
Colombia
51.3%
in 2021
Belarus rank
62nd
Colombia rank
59th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Belarus
- Colombia
How they compare
Colombia currently reports 51.3% against 50.0% in Belarus, a difference of 1.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Colombia ahead.
Belarus ranks 62nd and Colombia ranks 59th of 184 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.5% | 38.0% | 0.5% | Colombia |
| 2010s | 49.1% | 50.1% | 1.0% | Colombia |
| 2020s | 50.3% | 51.8% | 1.5% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Belarus or Colombia?
- Colombia, at 51.3% against 50.0% in Belarus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Belarus and Colombia?
- 1.3%, with Colombia ahead.
- How many years of comparable data are there for Belarus and Colombia?
- 6 years are reported by both, from 2000 to 2021.
- How do Belarus and Colombia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Belarus ranks 62nd and Colombia ranks 59th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.